Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Essex Bio-Technology ( (HK:1061) ) has provided an update.
Essex Bio-Technology Limited has announced that its board of directors will hold a meeting on August 26, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The board will also consider the potential declaration of an interim dividend, which could impact the company’s financial strategy and shareholder returns.
More about Essex Bio-Technology
Essex Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and marketing biopharmaceutical products, primarily targeting the healthcare sector.
Average Trading Volume: 1,622,743
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.02B
Learn more about 1061 stock on TipRanks’ Stock Analysis page.